BofA Securities downgraded Axcelis Tech from Buy to Neutral
Get the next $ACLS alert in real time by email
Chat with this insight
Save time and jump to the most important pieces.
Recent Analyst Ratings for $ACLS
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/12/2025 | Outperform → Mkt Perform | William Blair | |
| 11/8/2024 | Buy → Hold | The Benchmark Company | |
| 5/3/2024 | $130.00 | Hold → Buy | Craig Hallum |
| 12/15/2023 | Buy → Neutral | BofA Securities | |
| 9/15/2023 | $225.00 | Buy | BofA Securities |
| 8/4/2023 | $140.00 → $175.00 | Buy → Hold | Craig Hallum |
| 6/14/2023 | Buy → Hold | Needham | |
| 6/5/2023 | Outperform | William Blair |
Axcelis Announces Participation in SEMICON China 2025
President and CEO Russell Low will Present Keynote Speech at CS Asia BEVERLY, Mass., March 17, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will be the Diamond Sponsor for the Compound Semiconductor Asia Conference (CS Asia) 2025. The event is being held in conjunction with SEMICON China 2025 on March 25-27, 2025, at the Kerry Hotel in Pudong, Shanghai. Axcelis' President and CEO, Russell Low, will present an opening Keynote Speech at the event. I
Axcelis Announces $100 Million Increase to Share Repurchase Authorization
BEVERLY, Mass., March 12, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that its Board of Directors has approved an additional $100 million in share repurchase authorization. This approval brings the current outstanding repurchase authorization to $215 million. "Axcelis has maintained a strong cash position supported by solid execution over the past several years. This increased share repurchase authorization reflects our confidence in the attractive long-t
Axcelis Announces Participation in Upcoming Investor Conferences
BEVERLY, Mass., Feb. 18, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today the company's plans to participate in the following upcoming investor conferences: The Susquehanna Financial Group Fourteenth Annual Technology Conference, taking place at the Lotte New York Palace Hotel on February 27 and 28, 2025. Axcelis management will host one-on-one and small group meetings on Thursday, February 27th with interested investors. For more information on the conferenc
Axcelis Tech downgraded by William Blair
William Blair downgraded Axcelis Tech from Outperform to Mkt Perform
Axcelis Tech downgraded by The Benchmark Company
The Benchmark Company downgraded Axcelis Tech from Buy to Hold
Axcelis Tech upgraded by Craig Hallum with a new price target
Craig Hallum upgraded Axcelis Tech from Hold to Buy and set a new price target of $130.00
Low Russell bought $49,452 worth of shares (440 units at $112.39), increasing direct ownership by 0.77% to 57,754 units (SEC Form 4)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
Coogan James Gordon bought $11,223 worth of shares (100 units at $112.23), increasing direct ownership by 2% to 5,991 units (SEC Form 4)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
Lawson Douglas A. bought $55,520 worth of shares (500 units at $111.04), increasing direct ownership by 3% to 19,648 units (SEC Form 4)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
EVP Global Customer Operations Tatnall Christopher covered exercise/tax liability with 1,146 shares, decreasing direct ownership by 8% to 13,567 units (SEC Form 4)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
EVP, Research, Dev. & Eng. Blumenstock Gerald M covered exercise/tax liability with 748 shares, decreasing direct ownership by 7% to 10,250 units (SEC Form 4)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
PRESIDENT AND CEO Low Russell covered exercise/tax liability with 9,135 shares, decreasing direct ownership by 10% to 79,553 units (SEC Form 4)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
SEC Form DEF 14A filed by Axcelis Technologies Inc.
DEF 14A - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
Axcelis Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
Axcelis Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
Axcelis Technologies Appoints David Ryzhik Senior Vice President of Investor Relations and Corporate Strategy
The Company Announces Planned Retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy BEVERLY, Mass., June 27, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today named David Ryzhik as Senior Vice President of Investor Relations and Corporate Strategy, assuming responsibility for the role in July 2024. The Company also announced the retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy. Mr. Lawson plans to retire in July 2024 and will remain as a Senior Advisor through July 2025.
Axcelis Announces Shipment of 'Purion EXE SiC Power Series' Implanter and Successful 'Purion H200 SiC Power Series' Eval Closure at Leading Power Device Manufacturers in Japan
BEVERLY, Mass., April 2, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today a shipment of the Company's Purion EXE™ SiC high energy implanter as well as a successful Purion H200™ SiC medium energy implanter evaluation closure at leading power device chipmakers located in Japan. The systems will be used for 150mm and 200mm production of silicon carbide power devices supporting automotive, industrial, energy, and other power intensive applications. Greg Redinbo,
ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors
SOLANA BEACH, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global therapy-enabling platform company providing navigation and delivery to the brain, is pleased to announce that Lynnette C. Fallon has been appointed to the Company's Board of Directors effective immediately. Ms. Fallon will also become a member of the Company's Audit Committee. Ms. Fallon is the Executive Vice President, HR/Legal, General Counsel and Secretary of Axcelis Technologies, Inc. (NASDAQ:ACLS), a provider of equipment and service solutions for the semiconductor manufacturing industry, with locations in eight countries. Ms. Fallon has held her current position sin
Axcelis Announces Financial Results for Fourth Quarter and Full Year 2024
Q4 Highlights: Revenue of $252.4 millionOperating Margin of 21.6%Diluted earnings per share of $1.54BEVERLY, Mass., Feb. 10, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2024. For the full year 2024, the Company reported revenue of $1.02 billion, compared with $1.13 billion for the full year 2023. Systems revenue for the year was $782.6 million, compared to $883.6 million in 2023. Operating profit was $210.8 million in 2024, compared to $265.8 million in 2023. Net income
Axcelis Announces Timing and Availability of Fourth Quarter and Full Year 2024 Results and Conference Call
BEVERLY, Mass., Jan. 23, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the fourth quarter and full year 2024 after market close on Monday, February 10, 2025. The Company will host a call to discuss the results for the fourth quarter and full year 2024 on Tuesday, February 11, 2025, at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registeri
Axcelis Announces Financial Results for Third Quarter 2024
Revenue of $256.6 millionOperating margin of 18.3% Diluted earnings per share of $1.49BEVERLY, Mass., Nov. 6, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the third quarter ended September 30, 2024. The Company reported third quarter revenue of $256.6 million, compared to $256.5 million for the second quarter of 2024. Gross margin for the quarter was 42.9%, compared to 43.8% in the second quarter. Operating profit for the quarter was $46.9 million, compared to $52.8 million for the second quarter. Net income for the quarter was $48.6 million, or $1.49 per diluted share, compared to $50.9 million, or $1.55 per diluted share in the second
Amendment: SEC Form SC 13G/A filed by Axcelis Technologies Inc.
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SEC Form SC 13G/A filed by Axcelis Technologies Inc. (Amendment)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SEC Form SC 13G/A filed by Axcelis Technologies Inc. (Amendment)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)